Updated International Consensus Guidelines on the Management of Cytomegalovirus in Solid-Organ Transplantation
Top Cited Papers
- 27 August 2013
- journal article
- review article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 96 (4) , 333-360
- https://doi.org/10.1097/tp.0b013e31829df29d
Abstract
Cytomegalovirus (CMV) continues to be one of the most common infections after solid-organ transplantation, resulting in significant morbidity, graft loss, and adverse outcomes. Management of CMV varies considerably among transplant centers but has been become more standardized by publication of consensus guidelines by the Infectious Diseases Section of The Transplantation Society. An international panel of experts was reconvened in October 2012 to revise and expand evidence and expert opinion-based consensus guidelines on CMV management, including diagnostics, immunology, prevention, treatment, drug resistance, and pediatric issues. The following report summarizes the recommendations.Keywords
This publication has 253 references indexed in Scilit:
- Retrospective Review of the Incidence of Cytomegalovirus Infection and Disease After Liver Transplantation in Pediatric Patients: Comparison of Prophylactic Oral Ganciclovir and Oral ValganciclovirLiver Transplantation, 2011
- Cytomegalovirus DNA stability in EDTA anti-coagulated whole blood and plasma samplesJournal of Clinical Virology, 2011
- Human cytomegalovirus kinetics following institution of artesunate after hematopoietic stem cell transplantationAntiviral Research, 2011
- Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trialThe Lancet, 2011
- Cytomegalovirus Immunoglobulin Decreases the Risk of Cytomegalovirus Infection but not Disease After Pediatric Lung TransplantationThe Journal of Heart and Lung Transplantation, 2009
- Vaccine Prevention of Maternal Cytomegalovirus InfectionNew England Journal of Medicine, 2009
- Increased Mortality After Pulmonary Fungal Infection Within the First Year After Pediatric Lung TransplantationThe Journal of Heart and Lung Transplantation, 2008
- Pharmacokinetic and Pharmacodynamic Assessment of Oral Valganciclovir in the Treatment of Symptomatic Congenital Cytomegalovirus DiseaseThe Journal of Infectious Diseases, 2008
- Development and preclinical evaluation of an alphavirus replicon particle vaccine for cytomegalovirusVaccine, 2007
- Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjectsThe Journal of Experimental Medicine, 2005